{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-017970","form_type":"8-K","ticker":"VICP","cik":"0001468639","company_name":"Vicapsys Life Sciences, Inc.","filed_at":"2023-05-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.956732+00:00","generated_at":"2026-06-14T22:17:43.765902+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Vicapsys Life Sciences dismisses auditor D. Brooks and appoints Assurance Dimensions","bullets":["Board dismissed D. Brooks and Associates CPAs as independent auditor effective May 12, 2023.","Prior audit reports for FY2022 and FY2021 included a going-concern explanatory paragraph but no adverse opinions.","No disagreements or reportable events occurred during the two most recent fiscal years or interim period.","Board appointed Assurance Dimensions as new independent registered public accounting firm on May 12, 2023.","D. Brooks furnished a letter to the SEC, dated May 17, 2023, agreeing with the disclosure."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-017970","json":"https://secwatch.observer/filing/0001493152-23-017970.json","markdown":"https://secwatch.observer/filing/0001493152-23-017970.md","text":"https://secwatch.observer/filing/0001493152-23-017970.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1468639/000149315223017970/0001493152-23-017970-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1468639/000149315223017970/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T22:17:43.765902+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0c73d69f23ebeeff1ccfd8080f63ba916963245d","claim":"Vicapsys Life Sciences, Inc. engaged Assurance Dimensions as its auditor.","evidence_excerpt":"the Board appointed Assurance Dimensions. (“Assurance”) as the Company’s independent registered public accounting firm to audit the Company’s consolidated financial statements for the fiscal year ending December 31, 2023.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1468639/000149315223017970/0001493152-23-017970-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"Assurance Dimensions"}],"fact_type":"auditor_change"},{"claim_id":"54ed060ae90e79231ff2032dbcd3b7578c1ba9bd","claim":"Vicapsys Life Sciences, Inc. dismissed D. Brooks and Associates CPAs, P.A. as its auditor.","evidence_excerpt":"the Board of Directors (the “Board”) of the Vicapsys Life Sciences, Inc. (the “Company”) approved the dismissal of D. Brooks and Associates CPAs, P.A. (“D. Brooks”) as the Company’s independent registered public accounting firm effective May 12, 2023.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1468639/000149315223017970/0001493152-23-017970-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"dismissal"},{"label":"Auditor","value":"D. Brooks and Associates CPAs, P.A."}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}